Clinical trialNCT06764940RecruitingPhase 2Interventional

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

SponsorBiostar Pharma, Inc.Enrollment120HER2-negative Breast Cancer Patients With Brain Metastases

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

City of Hope--Duarte
Duarte, California, United States
Dr. Hope S. Rugo
Not, yet, recruiting
Cancer & Blood Research Center, Llc
Los Alamitos, California, United States
Dr. Vu Phan
Recruiting
Univ. of California Los Angeles
Los Angeles, California, United States
Rena Callahan
Not, yet, recruiting
Fomat Medical Research (network)
Oxnard, California, United States
Dr. Nawazish Khan
Recruiting
Scripps Health
San Diego, California, United States
Dr. Tresa McGranahan
Recruiting
University of Colorado Hospital - Anschutz Cancer Pavilion
Aurora, Colorado, United States
Dr. Elena Shagisultanova
Recruiting
Biosresearch Partner
Hialeah, Florida, United States
Dr. Luis Rangel
Recruiting
D&h Cancer Research Center
Margate, Florida, United States
Dr. Emilio Araujo-Mino
Recruiting
Augusta University
Augusta, Georgia, United States
Dr. Priyanka Raval
Recruiting
Robert H. Lurie Comprehensive Cancer Center Northwestern University
Chicago, Illinois, United States
Dr. Regina Stein
Recruiting
the Johns Hopkins Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Baltimore, Maryland, United States
Solmaz Sahebjam
Not, yet, recruiting
Profound Research Llc
Farmington Hills, Michigan, United States
Dr. Savitha Balaraman
Recruiting
Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
Dr. Liawaty Ho
Recruiting
Stony Brook Cancer Center
Stony Brook, New York, United States
Dr. Lea Baer
Recruiting
Md Anderson Cancer Center
Houston, Texas, United States
Dr. Nuhad Ibrahim
Recruiting
Community Clinical Trials
Kingwood, Texas, United States
Dr. Saleha Sajid
Recruiting
Tranquil Clinical Research
Webster, Texas, United States
Dr. John G. Knecht III
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Epothilone DUtidelone in combination with capecitabine

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 14 Jul 2025
Primary completion: 15 Jan 2027
Completion: 15 Jul 2027
Last update posted: 28 Nov 2025
Registered enrollment: 120
Registry id: NCT06764940

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.